Related Experiment Video

Updated: May 1, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

9.9K

Immunologic, metabolic and genetic factors in hepatitis C virus infection

Nora A Fierro1, Karina Gonzalez-Aldaco1, Rafael Torres-Valadez1

  • 1Nora A Fierro, Karina Gonzalez-Aldaco, Rafael Torres-Valadez, Erika Martinez-Lopez, Sonia Roman, Arturo Panduro, Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara, "Fray Antonio Alcalde" and Health Sciences Center, University of Guadalajara, Guadalajara 44280, Jalisco, Mexico.

World Journal of Gastroenterology
|April 8, 2014
PubMed

Insights

Understanding hepatitis C virus (HCV) progression requires studying immune, genetic, and metabolic factors, especially in relation to obesity and ethnic characteristics. This research highlights potential therapeutic targets for HCV infection outcomes.

Area of Science:

  • Hepatology
  • Immunology
  • Metabolic Research

Background:

  • Mechanisms regulating Hepatitis C Virus (HCV) disease progression and treatment response remain unclear.
  • Host immune response, genetic factors, and cholesterol modulation are implicated in HCV infection.
  • The global obesity epidemic, prevalent in Mexico and the US, is linked to hypercholesterolemia, a major mortality risk factor.

Purpose of the Study:

  • To investigate the urgent need for studying HCV infection progression concerning ethnic characteristics.
  • To explore the interplay of immune, metabolic, and genetic factors in HCV outcomes.
  • To identify potential therapeutic targets and predictors for HCV infection.

Main Methods:

  • Review of existing literature on HCV infection mechanisms.
  • Analysis of the role of host immunity, genetics, and cholesterol metabolism.
  • Consideration of epidemiological data on obesity and hypercholesterolemia in specific populations.

Main Results:

  • A strong host immune response is associated with HCV clearance.
  • Cholesterol modulation and genetic factors significantly influence HCV infection.
  • Obesity and associated hypercholesterolemia may impact HCV progression, particularly in certain ethnic groups.

Conclusions:

  • The interplay of immune, metabolic, and genetic factors is crucial for understanding HCV progression.
  • Ethnic characteristics should be considered in HCV research.
  • Discoveries in these areas offer promise for identifying novel therapeutic targets and predictive biomarkers for HCV infection.

Keywords:
GeneticsHepatitis C virusImmune responseLipidsMetabolism

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.2K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

23.7K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
818
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271